NSTEMI and Coronary Amyloid Infiltration: Challenges and Therapeutic Strategies in CHU Ibn Rochd, Casablanca
A. Al-Timimi
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
L. Afendi
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
F. Essadqi *
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
A. El Bouazizi
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
M. Bouziane
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
M. Haboub
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
S. Arous
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
G. Benouna
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
A. Drighil
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
R. Habbal
Department of Cardiology, CHU Ibn Rochd, Casablanca, Morocco.
*Author to whom correspondence should be addressed.
Abstract
Acute coronary syndromes (ACS) are major cardiovascular emergencies requiring prompt and appropriate management to reduce complications and improve prognosis. We report an unusual case of high-risk non-ST-segment elevation myocardial infarction (NSTEMI) in a 63-year-old patient with hypertrophic cardiomyopathy (HCM) and coronary amyloid infiltration. Cardiac investigations revealed severe triple-vessel coronary artery disease with myocardial necrosis sequelae, leading to the recommendation for coronary artery bypass grafting (CABG). This rare association complicates management due to structural alterations from amyloid infiltration, increasing ischemic and arrhythmic risks. This case highlights the importance of a multidisciplinary approach and rigorous follow-up to adapt therapeutic strategies to complex clinical presentations.
Keywords: Acute coronary syndromes, hypertrophic cardiomyopathy, amyloid infiltration, myocardial necrosis sequelae